BiomEdit LLC.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BiomEdit LLC. - overview
Established
2022
Location
Fishers, IN, US
Primary Industry
Biotechnology
About
BiomEdit LLC, based in the US, focuses on developing innovative microbiome-derived solutions that enhance animal health by leveraging the microbial ecosystems of animals to prevent disease and promote overall well-being. BiomEdit LLC is dedicated to creating microbiome-derived products that improve animal health. Founded in 2022 and based in Fishers, Indiana, US, the company has successfully completed 6 deals. Its latest funding round occurred on October 23, 2025, when it received USD 2.
000 mn in GRANT funding from the Bezos Earth Fund, bringing the total amount raised to USD 16. 044 mn. The current CEO is Aaron Schacht. BiomEdit specializes in microbiome-derived products designed to enhance animal health.
These offerings utilize the animal's own microbial ecosystem to create solutions that prevent disease and support well-being. Their target clients include veterinarians, livestock producers, and pet owners, with products applicable to both companion animals and agricultural livestock. The company primarily markets its products in North America and Europe while considering expansion into emerging markets. BiomEdit generates revenue through partnerships and collaborations within the animal health sector.
Sales are made directly to veterinary practices, agricultural retailers, and wholesale distributors, ensuring wide product accessibility. The company may also adopt subscription models for ongoing veterinary services or product replenishment, thereby fostering long-term relationships with clients. Pricing structures are tailored to accommodate various scales of use, catering to both small pet owners and large agricultural enterprises. In October 2025, BiomEdit LLC received USD 2.
000 mn in grant funding from the Bezos Earth Fund, which will be utilized to develop an AI-powered Rumen Digital Twin aimed at identifying effective methane-reduction strategies in cattle while also optimizing productivity and welfare. The company plans to introduce this innovative product in conjunction with its strategy to expand into new markets, particularly targeting regions in North America and Europe by 2026.
Current Investors
Viking Global Investors, Anterra Capital, Ginkgo BioWorks Inc.
Primary Industry
Biotechnology
Sub Industries
Consulting Services, Bioinformatics
Website
www.biomedit.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
BiomEdit LLC. - employee data
BiomEdit LLC. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board Of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.